At the heart of this integration is Neutec's flagship LabMaster product, now equipped with a Bioz Prime Badge that dynamically showcases peer-reviewed publications citing the product. Impressively, ...
Swiss pharmaceutical major Novartis said today it owns more than three quarters of the shares in UK anti-infective specialist NeuTec, passing the threshold for taking control of the company. Swiss ...
Swiss pharmaceutical giant Novartis has agreed to buy British firm NeuTec Pharma , a specialist in fighting hospital superbugs, for $569 million. The NeuTec board of directors has recommended the ...
MANCHESTER biotech business NeuTec Pharma today accepted a é305m takeover from Swiss pharmaceutical giant Novartis. The 1050p per share cash offer is twice the closing price of NeuTecés closing price ...
Switzerland’s Novartis this morning said it is snapping up UK biotechnology company NeuTec – which specialises in anti-infectives for use in the secondary care setting and has one late-stage product ...
Novartis, in the third transaction this week to secure experimental drugs, agreed to buy the British company NeuTec Pharma for almost twice its market value. Europe's third-largest drugmaker offered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results